STRS Ohio
LBRX icon

STRS Ohio’s LB Pharmaceuticals LBRX Stock Holding History

STRS Ohio’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$530K Buy
+13,800
New +$570K ﹤0.01% 1202
2026
Q2 		– Sell
-5,100
Closed -$126K – 2371
2026
Q1 		$126K Buy
5,100
+1,700
+50% +$39.2K ﹤0.01% 1695
2025
Q4 		$75.7K Buy
+3,400
New +$59.4K ﹤0.01% 1885

Other funds holding LBRX

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Meyer Handelman Company
Meyer Handelman Company Rye Brook, New York $3.49B AUM 26.82% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

STRS Ohio's LBRX Position: Q3 2026 in Review

STRS Ohio opened a new position in LB Pharmaceuticals (LBRX) in Q3 2026: 13,800 shares worth $530K. The stake represents ﹤0.01% of the portfolio and ranks #1202 among its holdings. This is a return to the name: STRS Ohio previously reported a position in LBRX as recently as Q1 2026.

STRS Ohio first reported a position in LBRX in Q4 2025 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.

  • STRS Ohio held 13,800 shares of LB Pharmaceuticals worth $530K as of Q3 2026.
  • LB Pharmaceuticals was a new STRS Ohio position in Q3 2026.
  • LB Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #1202 holding.
  • STRS Ohio first reported a position in LB Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 19 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.